摘要
目的复习家族性高胆固醇血症的药物治疗。方法通过回顾一例病例结合相关文献进行分析。结果除了对治疗剂量的认识有所加深外,目前临床尚未有更好的治疗药物,治疗手段也极为有限。
出处
《今日药学》
CAS
2008年第5期52-53,共2页
Pharmacy Today
参考文献4
-
1[2]Hawk CJ.Mon-steroidal anti-inflammatory drug and peptic uleers.Br med J 1990;300(6720):278-284
-
2[5]Rostom A,et al.prevention of NSAID induced gastroduodenal ulceration (cochrane Review).cochrane Database syst Rey 2002;(4)C0002296.
-
3[6]Daniel j,cohen RJ,Hobbs HH,et al.Monogenic hypercholesterolemia:new insights in pathogenesis and treatment[J].J Clin Invest,2003,111:1795-1803
-
4梁磊,廖端芳.新型降脂药依泽替米贝的研究进展[J].国外医学(药学分册),2006,33(2):117-119. 被引量:4
二级参考文献17
-
1Rosenhlum SB, Huynh T, Afonso A, et al. Disoovery of 1-(4-fluropheny1 )-( 3R )-[ 3- (4-fluorophenyl) -3 S-hydroxypropy1 ]-(4S )-(4-hydroxypropy1 )-2-azetidinone ( SCH 58235 ) : a designed, potent,orally active inhibitor of cholesterol absorption [ J ]. J Med Chem,1998, 41(6) :973 - 980.
-
2Rudel LL. Preclinical and clinical pharmacology of a new class of lipid management agents[J]. Am J Manag Care, 2002, 8(2 Suppl) :S33 - S37.
-
3Landmesser U, Bahlmann F, Mueller M, et al. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans[J]. Circulation, 2005, 111(18):2356-2363.
-
4Davis HR Jr, Zhu I J, Hoos LM, et al. Niemann-Piek C1 like 1(NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis [ J ]. J Biol Chem, 2004, 279(32) :33586 - 33592.
-
5Smart EJ, De Rose RA, Father SA. Annexin-2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport[J].Proc Natl Acad Sci USA, 2004, 101 (10) : 3450 - 3455.
-
6Valasek MA, Weng J, Shaul PW, et al. Caveolin-1 is not required for murine intestinal cholesterol transport [ J ]. J Biol Chem, 2005,280(30) :28103 - 28109.
-
7Frick W, Bauer-Schafer A, Bauer J, et al. Synthesis of a biotintagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors[J]. Bioorg Med Chem, 2003, 11(8) :1639- 1642.
-
8Kramer W, Girbig F, Corsiero D, et al. Aminopeptidase N (CD13)is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane[J]. J Biol Chem, 2005,280(2) : 1306 - 1320.
-
9Harry RD Jr, Douglas SC, Lizbeth H, et al. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice arteriosclerosis [ J ]. Thromb Vasc Biol, 2001, 21:2032 - 2038.
-
10Davis HR Jr, Ptda KK, Alton KB, et al. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor,ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs [ J ]. Metabolism, 2001, 50 (10) :1234- 1241.
共引文献3
-
1倪春峰,李志裕.HMG-CoA还原酶抑制剂研究进展[J].海峡药学,2007,19(8):12-15. 被引量:2
-
2严宾,袁拥军.依泽替米贝合成工艺研究[J].现代医药卫生,2015,31(24):3712-3713.
-
3徐红伟,王大军,罗羽田,王迎,王建国.腹腔镜下保胆取石术结合依泽替米贝术前口服对胆囊结石患者血清皮质醇及促肾上腺皮质激素表达的影响[J].中国医学工程,2020,28(5):17-21. 被引量:2
同被引文献10
-
1蓝松.跟腱黄色瘤病伴脑损害性病变1例[J].诊断病理学杂志,2003,10(5):280-280. 被引量:5
-
2Tsouli SG, Kiortsis DN, Argyroponlon ML, et al. Patho genesis,detection and treatment of achilles tendon xantho ma[J]. Eur J Clin Invest,2005,35(4) :236-244.
-
3王加伟,徐雷鸣,吴瑾绣.腱黄色瘤MR表现二例[J].临床放射学杂志,2008,27(5):705-706. 被引量:8
-
4何震明,王健全,印钰,刘睿.跟腱黄色瘤手术治疗一例[J].中华外科杂志,2008,46(14):1119-1119. 被引量:6
-
5刘学蓉.高胆固醇血症黄色瘤病一家系2例[J].四川医学,2008,29(10):1405-1406. 被引量:1
-
6郭晟,白少华,高燕军,邬小平,杨军乐.腱黄色瘤3例影像表现[J].现代医用影像学,2009,18(3):185-187. 被引量:4
-
7李丽华.家族性黄色瘤3例[J].河北医药,2010,32(12):1654-1654. 被引量:1
-
8印建国,方国庆,贾雄.多发性结节性黄色瘤2例[J].疑难病杂志,2010,9(12):941-941. 被引量:3
-
9蒙翠原,邱前辉,苏小妹,冼宇飞,庄恒国.家族性高胆固醇血症合并双侧颞骨黄色瘤一例报告并文献复习[J].中华耳科学杂志,2011,9(4):426-429. 被引量:7
-
10董旭霞,高建根,蒋廷宠.跟腱黄色瘤一例[J].放射学实践,2011,26(12):1341-1341. 被引量:6
-
1高丽玲.力平脂治疗高血脂症33例分析[J].福建医药杂志,1994,16(5):28-29.
-
2吴斌.阿托伐他汀的药理作用及临床应用分析[J].中国医药指南,2014,12(10):185-185. 被引量:7
-
3张春华,冯卉.阿托伐他汀的药理作用及临床应用分析[J].中国医药指南,2012,10(26):121-122. 被引量:3
-
4王南,陈琪,陈秀英,蔡海江,程蕴林,鲁翔,陈建国.辛伐他丁对家族性高胆固醇血症降脂作用的研究[J].江苏医药,1998,24(4):248-249.
-
5梁艳.二氧化碳激光治疗眼睑黄色瘤32例[J].南京部队医药,2002,4(4).
-
6郭宇超,刘震宇,张抒扬.家族性高胆固醇血症的药物治疗现状和进展[J].国际药学研究杂志,2017,44(2):135-139. 被引量:3
-
7EMA评估瑞舒伐他汀的糖尿病风险[J].中国执业药师,2011,8(2):20-21.
-
8曾令济,张凤珍.先天性黄瘤1例[J].中国皮肤性病学杂志,2006,20(7):445-446.
-
9陈怀民.普伐他汀在家族性高胆固醇血症儿童的药效学和药代动力学[J].国外医学(心血管疾病分册),2003,30(6):369-369.
-
10陆宗良,杜保民.阿托伐他汀长期治疗纯合子家族性高胆固醇血症1例[J].中国新药杂志,2000,9(6):403-404. 被引量:10